David Vesey
Department of biomedical Sciences
Translational Research Institute
Australia
Biography
David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development (Ortho Clinical Diagnostics); artificial liver machine development (Imperial College); and p53 mutations in liver cancer (QIMR). He joined the Department of Nephrology at the Princess Alexandra Hospital in Brisbane in 1999. He is a senior lecturer in The University of Queensland Faculty of Medicine, a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra Hospital Endotoxin Testing Service.
Research Interest
Kidney disease
Publications
-
Carneiro MFH, Morais C, Small D, Vesey DA, Barbosa F Jr, Gobe G. Thimerosal Induces Apoptotic and Fibrotic Changes to Kidney Epithelial Cells In Vitro. Environmental Toxicology (Accepted June 20 14)
-
Morais C, Small D, Vesey DA, Martin J, Johnson D, Gobe G. Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochem Biophys Res Commun 444:332-7, 2014
-
Suen JY, Cotterell A, Lohman RJ, Lim J, Han A, Yau MK, Liu L, Cooper MA, Vesey DA, Fairlie DP. Pathway-selective antagonism of proteinase activated receptor 2.Br J Pharmacol. 2014 171:4112-24.
